Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management

Circulation

Volumn 137, Issue 13, 2018, Pages 1391-1406

  Neeland, Ian J ^a   Poirier, Paul ^b   Després, Jean Pierre ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

adiposity; cardiac imaging techniques; cardiovascular diseases; obesity; risk factors; waist circumference

Indexed keywords

AMFEBUTAMONE; AMFEBUTAMONE PLUS NALTREXONE; LIRAGLUTIDE; LORCASERIN; NALTREXONE; PHENTERMINE PLUS TOPIRAMATE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; ANOREXIGENIC AGENT;

ABDOMINAL OBESITY; ADIPOGENESIS; ADIPOSE TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY COMPOSITION; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT LOSS; BROWN ADIPOSE TISSUE; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; EXERCISE; FAT MASS; FLATULENCE; GASTRIC BANDING; GASTRIC BYPASS SURGERY; GASTRIC SLEEVE; GLUCOSE TOLERANCE; HEADACHE; HEART FAILURE; HUMAN; HYPERTENSION; INSOMNIA; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIFESTYLE MODIFICATION; LIPID OXIDATION; LIPID STORAGE; MEDITERRANEAN DIET; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PANCREATITIS; PHENOTYPE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STEATORRHEA; SUBCUTANEOUS FAT; SYSTEMIC VASCULAR RESISTANCE; VOMITING; WAIST CIRCUMFERENCE; XEROSTOMIA; COMPLICATION; METABOLIC DISORDER; METABOLISM; PATHOLOGY;

ADIPOSE TISSUE; ADIPOSITY; APPETITE DEPRESSANTS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; HUMANS; METABOLIC DISEASES; OBESITY; RISK FACTORS;

EID: 85047299785     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.029617     Document Type: Article

References (109)

1. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, Marczak L, Mokdad AH, Moradi-Lakeh M, Naghavi M, Salama JS, Vos T, Abate KH, Abbafati C, Ahmed MB, Al-Aly Z, Alkerwi A, Al-Raddadi R, Amare AT, Amberbir A, Amegah AK, Amini E, Amrock SM, Anjana RM, Ärnlöv J, Asayesh H, Banerjee A, Barac A, Baye E, Bennett DA, Beyene AS, Biadgilign S, Biryukov S, Bjertness E, Boneya DJ, Campos-Nonato I, Carrero JJ, Cecilio P, Cercy K, Ciobanu LG, Cornaby L, Damtew SA, Dandona L, Dandona R, Dharmaratne SD, Duncan BB, Eshrati B, Esteghamati A, Feigin VL, Fernandes JC, Fürst T, Gebrehiwot TT, Gold A, Gona PN, Goto A, Habtewold TD, Hadush KT, Hafezi-Nejad N, Hay SI, Horino M, Islami F, Kamal R, Kasaeian A, Katikireddi SV, Kengne AP, Kesavachandran CN, Khader YS, Khang YH, Khubchandani J, Kim D, Kim YJ, Kinfu Y, Kosen S, Ku T, Defo BK, Kumar GA, Larson HJ, Leinsalu M, Liang X, Lim SS, Liu P, Lopez AD, Lozano R, Majeed A, Malekzadeh R, Malta DC, Mazidi M, McAlinden C, McGarvey ST, Mengistu DT, Mensah GA, Mensink GBM, Mezgebe HB, Mirrakhimov EM, Mueller UO, Noubiap JJ, Obermeyer CM, Ogbo FA, Owolabi MO, Patton GC, Pourmalek F, Qorbani M, Rafay A, Rai RK, Ranabhat CL, Reinig N, Safiri S, Salomon JA, Sanabria JR, Santos IS, Sartorius B, Sawhney M, Schmidhuber J, Schutte AE, Schmidt MI, Sepanlou SG, Shamsizadeh M, Sheikhbahaei S, Shin MJ, Shiri R, Shiue I, Roba HS, Silva DAS, Silverberg JI, Singh JA, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadese F, Tedla BA, Tegegne BS, Terkawi AS, Thakur JS, Tonelli M, Topor-Madry R, Tyrovolas S, Ukwaja KN, Uthman OA, Vaezghasemi M, Vasankari T, Vlassov VV, Vollset SE, Weiderpass E, Werdecker A, Wesana J, Westerman R, Yano Y, Yonemoto N, Yonga G, Zaidi Z, Zenebe ZM, Zipkin B, Murray CJL, GBD 2015 Obesity Collaborators Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 2017 377 13 27. doi: 10.1056/NEJMoa1614362.
2. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov VV, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E, Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014 384 766 781. doi: 10.1016/S0140-6736(14)60460-8.
3. Adult Obesity in the United States. The State of Obesity website. http://stateofobesity.org/adult-obesity. Accessed March 8, 2018
4. Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organ Tech Rep Ser 2000 894 i xii, 1253
5. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ, Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010 363 2211 2219
6. Tchernof A, Després JP, Pathophysiology of human visceral obesity: an update. Physiol Rev 2013 93 359 404. doi: 10.1152/physrev.00033.2011.
7. González-Muniesa P, Mártinez-González MA, Hu FB, Després JP, Matsuzawa Y, Loos RJF, Moreno LA, Bray GA, Martinez JA, Obesity. Nat Rev Dis Primers 2017 3 17034. doi: 10.1038/nrdp.2017.34.
8. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 129 suppl 2 S49 S73. doi: 10.1161/01.cir.0000437741.48606.98.
9. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR, The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008 168 1617 1624. doi: 10.1001/archinte.168.15.1617.
10. Després JP, Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012 126 1301 1313. doi: 10.1161/CIRCULATIONAHA.111.067264.
11. Lavie CJ, Milani RV, Ventura HO, Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009 53 1925 1932. doi: 10.1016/j.jacc.2008.12.068.
12. Lainscak M, von Haehling S, Doehner W, Anker SD, The obesity paradox in chronic disease: facts and numbers. J Cachexia Sarcopenia Muscle 2012 3 1 4. doi: 10.1007/s13539-012-0059-5.
13. Hainer V, Aldhoon-Hainerová I, Obesity paradox does exist. Diabetes Care 2013 36 suppl 2 S276 S281. doi: 10.2337/dcS13-2023.
14. Standl E, Erbach M, Schnell O, Defending the con side: obesity paradox does not exist. Diabetes Care 2013 36 suppl 2 S282 S286. doi: 10.2337/dcS13-2040.
15. Wang ZJ, Zhou YJ, Galper BZ, Gao F, Yeh RW, Mauri L, Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis. Heart 2015 101 1631 1638. doi: 10.1136/heartjnl-2014-307119.
16. Bagheri M, Speakman JR, Shabbidar S, Kazemi F, Djafarian K, A dose-response meta-analysis of the impact of body mass index on stroke and all-cause mortality in stroke patients: a paradox within a paradox. Obes Rev 2015 16 416 423. doi: 10.1111/obr.12272.
17. Kamel HK, Iqbal MA, Body mass index and mortality among hospitalized elderly patients. Arch Intern Med 2001 161 1459 1460
18. Banack HR, Kaufman JS, Does selection bias explain the obesity paradox among individuals with cardiovascular disease? Ann Epidemiol 2015 25 342 349. doi: 10.1016/j.annepidem.2015.02.008.
19. Lajous M, Banack HR, Kaufman JS, Hernán MA, Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am J Med 2015 128 334 336. doi: 10.1016/j.amjmed.2014.10.043.
20. Loprinzi P, Smit E, Lee H, Crespo C, Andersen R, Blair SN, The "fit but fat" paradigm addressed using accelerometer-determined physical activity data. N Am J Med Sci 2014 6 295 301. doi: 10.4103/1947-2714.136901.
21. Loprinzi PD, Application of the "fat-but-fit" paradigm in predicting 10-yr risk for an atherosclerotic cardiovascular disease (ASCVD) event using the pooled cohort risk equations among US adults. Int J Cardiol 2016 202 297 299. doi: 10.1016/j.ijcard.2015.09.057.
22. McAuley PA, Beavers KM, Contribution of cardiorespiratory fitness to the obesity paradox. Prog Cardiovasc Dis 2014 56 434 440. doi: 10.1016/j.pcad.2013.09.006.
23. Bays HE, Adiposopathy: is "sick fat" a cardiovascular disease? J Am Coll Cardiol 2011 57 2461 2473. doi: 10.1016/j.jacc.2011.02.038.
24. Kusminski CM, Holland WL, Sun K, Park J, Spurgin SB, Lin Y, Askew GR, Simcox JA, McClain DA, Li C, Scherer PE, MitoNEET-driven alterations in adipocyte mitochondrial activity reveal a crucial adaptive process that preserves insulin sensitivity in obesity. Nat Med 2012 18 1539 1549. doi: 10.1038/nm.2899.
25. Tran TT, Yamamoto Y, Gesta S, Kahn CR, Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008 7 410 420. doi: 10.1016/j.cmet.2008.04.004.
26. Bouchard C, Tremblay A, Després JP, Nadeau A, Lupien PJ, Thériault G, Dussault J, Moorjani S, Pinault S, Fournier G, The response to long-term overfeeding in identical twins. N Engl J Med 1990 322 1477 1482. doi: 10.1056/NEJM199005243222101.
27. Ross R, Aru J, Freeman J, Hudson R, Janssen I, Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002 282 E657 E663. doi: 10.1152/ajpendo.00469.2001.
28. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, Grundy SM, Khera A, McGuire DK, de Lemos JA, Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012 308 1150 1159. doi: 10.1001/2012.jama.11132.
29. Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, Vega GL, Khera A, McGuire DK, Grundy SM, de Lemos JA, Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring) 2013 21 E439 E447. doi: 10.1002/oby.20135.
30. Divoux A, Karastergiou K, Xie H, Guo W, Perera RJ, Fried SK, Smith SR, Identification of a novel lncRNA in gluteal adipose tissue and evidence for its positive effect on preadipocyte differentiation. Obesity (Silver Spring) 2014 22 1781 1785. doi: 10.1002/oby.20793.
31. Araneta MR, Kanaya AM, Hsu WC, Chang HK, Grandinetti A, Boyko EJ, Hayashi T, Kahn SE, Leonetti DL, McNeely MJ, Onishi Y, Sato KK, Fujimoto WY, Optimum BMI cut points to screen Asian Americans for type 2 diabetes. Diabetes Care 2015 38 814 820. doi: 10.2337/dc14-2071.
32. Nazare JA, Smith JD, Borel AL, Haffner SM, Balkau B, Ross R, Massien C, Alméras N, Després JP, Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity. Am J Clin Nutr 2012 96 714 726. doi: 10.3945/ajcn.112.035758.
33. Shah AD, Kandula NR, Lin F, Allison MA, Carr J, Herrington D, Liu K, Kanaya AM, Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the MASALA and MESA studies. Int J Obes (Lond) 2016 40 639 645. doi: 10.1038/ijo.2015.219.
34. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group The metabolic syndrome: a new worldwide definition. Lancet 2005 366 1059 1062. doi: 10.1016/S0140-6736(05)67402-8.
35. Després JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C, Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. Arterioscler Thromb Vasc Biol 2000 20 1932 1938
36. Chandra A, Neeland IJ, Berry JD, Ayers CR, Rohatgi A, Das SR, Khera A, McGuire DK, de Lemos JA, Turer AT, The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study. J Am Coll Cardiol 2014 64 997 1002. doi: 10.1016/j.jacc.2014.05.057.
37. Neeland IJ, Turer AT, Ayers CR, Berry JD, Rohatgi A, Das SR, Khera A, Vega GL, McGuire DK, Grundy SM, de Lemos JA, Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol 2015 65 2150 2151. doi: 10.1016/j.jacc.2015.01.061.
38. Neeland IJ, Gupta S, Ayers CR, Turer AT, Rame JE, Das SR, Berry JD, Khera A, McGuire DK, Vega GL, Grundy SM, de Lemos JA, Drazner MH, Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging 2013 6 800 807. doi: 10.1161/CIRCIMAGING.113.000532.
39. Yano Y, Vongpatanasin W, Ayers C, Turer A, Chandra A, Carnethon MR, Greenland P, de Lemos JA, Neeland IJ, Regional fat distribution and blood pressure level and variability: the Dallas Heart Study. Hypertension 2016 68 576 583. doi: 10.1161/HYPERTENSIONAHA.116.07876.
40. Levelt E, Pavlides M, Banerjee R, Mahmod M, Kelly C, Sellwood J, Ariga R, Thomas S, Francis J, Rodgers C, Clarke W, Sabharwal N, Antoniades C, Schneider J, Robson M, Clarke K, Karamitsos T, Rider O, Neubauer S, Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes. J Am Coll Cardiol 2016 68 53 63. doi: 10.1016/j.jacc.2016.03.597.
41. Lyall DM, Celis-Morales C, Ward J, Iliodromiti S, Anderson JJ, Gill JMR, Smith DJ, Ntuk UE, Mackay DF, Holmes MV, Sattar N, Pell JP, Association of body mass index with cardiometabolic disease in the UK Biobank: a mendelian randomization study. JAMA Cardiol 2017 2 882 889. doi: 10.1001/jamacardio.2016.5804.
42. Chatterjee NA, Giulianini F, Geelhoed B, Lunetta KL, Misialek JR, Niemeijer MN, Rienstra M, Rose LM, Smith AV, Arking DE, Ellinor PT, Heeringa J, Lin H, Lubitz SA, Soliman EZ, Verweij N, Alonso A, Benjamin EJ, Gudnason V, Stricker BHC, Van Der Harst P, Chasman DI, Albert CM, Genetic obesity and the risk of atrial fibrillation: causal estimates from mendelian randomization. Circulation 2017 135 741 754. doi: 10.1161/CIRCULATIONAHA.116.024921.
43. Emdin CA, Khera AV, Natarajan P, Klarin D, Zekavat SM, Hsiao AJ, Kathiresan S, Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease. JAMA 2017 317 626 634. doi: 10.1001/jama.2016.21042.
44. Manolopoulos KN, Karpe F, Frayn KN, Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond) 2010 34 949 959. doi: 10.1038/ijo.2009.286.
45. Gupta A, Pandey A, Ayers C, Beg MS, Lakoski SG, Vega GL, Grundy SM, Johnson DH, Neeland IJ, An analysis of individual body fat depots and risk of developing cancer: insights from the Dallas Heart Study. Mayo Clin Proc 2017 92 536 543. doi: 10.1016/j.mayocp.2016.12.023.
46. Pouliot MC, Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C, Regional variation in adipose tissue lipoprotein lipase activity: association with plasma high density lipoprotein levels. Eur J Clin Invest 1991 21 398 405
47. Rebuffé-Scrive M, Enk L, Crona N, Lönnroth P, Abrahamsson L, Smith U, Björntorp P, Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest 1985 75 1973 1976. doi: 10.1172/JCI111914.
48. Janiszewski PM, Kuk JL, Ross R, Is the reduction of lower-body subcutaneous adipose tissue associated with elevations in risk factors for diabetes and cardiovascular disease? Diabetologia 2008 51 1475 1482. doi: 10.1007/s00125-008-1058-0.
49. Loh RKC, Kingwell BA, Carey AL, Human brown adipose tissue as a target for obesity management; beyond cold-induced thermogenesis. Obes Rev 2017 18 1227 1242. doi: 10.1111/obr.12584.
50. Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, Kuo FC, Palmer EL, Tseng YH, Doria A, Kolodny GM, Kahn CR, Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009 360 1509 1517. doi: 10.1056/NEJMoa0810780.
51. Orava J, Nuutila P, Lidell ME, Oikonen V, Noponen T, Viljanen T, Scheinin M, Taittonen M, Niemi T, Enerbäck S, Virtanen KA, Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab 2011 14 272 279. doi: 10.1016/j.cmet.2011.06.012.
52. Ouellet V, Labbé SM, Blondin DP, Phoenix S, Guérin B, Haman F, Turcotte EE, Richard D, Carpentier AC, Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 2012 122 545 552. doi: 10.1172/JCI60433.
53. Kim SH, Plutzky J, Brown fat and browning for the treatment of obesity and related metabolic disorders. Diabetes Metab J 2016 40 12 21. doi: 10.4093/dmj.2016.40.1.12.
54. Chondronikola M, Volpi E, Børsheim E, Porter C, Annamalai P, Enerbäck S, Lidell ME, Saraf MK, Labbe SM, Hurren NM, Yfanti C, Chao T, Andersen CR, Cesani F, Hawkins H, Sidossis LS, Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes 2014 63 4089 4099. doi: 10.2337/db14-0746.
55. Blondin DP, Labbé SM, Phoenix S, Guérin B, Turcotte ÉE, Richard D, Carpentier AC, Haman F, Contributions of white and brown adipose tissues and skeletal muscles to acute cold-induced metabolic responses in healthy men. J Physiol 2015 593 701 714. doi: 10.1113/jphysiol.2014.283598.
56. Bays HE, González-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR, Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008 6 343 368. doi: 10.1586/14779072.6.3.343.
57. Murase T, Hattori T, Ohtake M, Abe M, Amakusa Y, Takatsu M, Murohara T, Nagata K, Cardiac remodeling and diastolic dysfunction in DahlS.Z-Lepr(fa)/Lepr(fa) rats: a new animal model of metabolic syndrome. Hypertens Res 2012 35 186 193. doi: 10.1038/hr.2011.157.
58. Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, Khera A, McGuire DK, Vega GL, de Lemos JA, Turer AT, Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile. J Am Coll Cardiol 2013 62 752 760. doi: 10.1016/j.jacc.2013.03.038.
59. Arora P, Reingold J, Baggish A, Guanaga DP, Wu C, Ghorbani A, Song Y, Chen-Tournaux A, Khan AM, Tainsh LT, Buys ES, Williams JS, Heublein DM, Burnett JC, Semigran MJ, Bloch KD, Scherrer-Crosbie M, Newton-Cheh C, Kaplan LM, Wang TJ, Weight loss, saline loading, and the natriuretic peptide system. J Am Heart Assoc 2015 4 e001265. doi: 10.1161/JAHA.114.001265.
60. Sengenès C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J, Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 2000 14 1345 1351
61. Bordicchia M, Liu D, Amri EZ, Ailhaud G, Dessì-Fulgheri P, Zhang C, Takahashi N, Sarzani R, Collins S, Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 2012 122 1022 1036. doi: 10.1172/JCI59701.
62. Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, Sone M, Yamahara K, Taura D, Inuzuka M, Sonoyama T, Nakao K, Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 2009 58 2880 2892. doi: 10.2337/db09-0393.
63. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, Okazaki H, Asai M, Nagamachi Y, Maeda N, Shintani Y, Minamino T, Asakura M, Kishimoto I, Funahashi T, Tomoike H, Kitakaze M, Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 2009 53 2070 2077. doi: 10.1016/j.jacc.2009.02.038.
64. Engeli S, Birkenfeld AL, Badin PM, Bourlier V, Louche K, Viguerie N, Thalamas C, Montastier E, Larrouy D, Harant I, de Glisezinski I, Lieske S, Reinke J, Beckmann B, Langin D, Jordan J, Moro C, Natriuretic peptides enhance the oxidative capacity of human skeletal muscle. J Clin Invest 2012 122 4675 4679. doi: 10.1172/JCI64526.
65. McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014 371 993 1004. doi: 10.1056/NEJMoa1409077.
66. Rui L, Energy metabolism in the liver. Compr Physiol 2014 4 177 197. doi: 10.1002/cphy.c130024.
67. Neeland IJ, Hughes C, Ayers CR, Malloy CR, Jin ES, Effects of visceral adiposity on glycerol pathways in gluconeogenesis. Metabolism 2017 67 80 89. doi: 10.1016/j.metabol.2016.11.008.
68. Diaz-Melean CM, Somers VK, Rodriguez-Escudero JP, Singh P, Sochor O, Llano EM, Lopez-Jimenez F, Mechanisms of adverse cardiometabolic consequences of obesity. Curr Atheroscler Rep 2013 15 364. doi: 10.1007/s11883-013-0364-2.
69. Després JP, What is "metabolically healthy obesity?" From epidemiology to pathophysiological insights. J Clin Endocrinol Metab 2012 97 2283 2285. doi: 10.1210/jc.2012-2081.
70. Phillips CM, Metabolically healthy obesity: definitions, determinants and clinical implications. Rev Endocr Metab Disord 2013 14 219 227. doi: 10.1007/s11154-013-9252-x.
71. Kramer CK, Zinman B, Retnakaran R, Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 2013 159 758 769. doi: 10.7326/0003-4819-159-11-201312030-00008.
72. Mørkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I, Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trøndelag Health Study), Norway. J Am Coll Cardiol 2014 63 1071 1078. doi: 10.1016/j.jacc.2013.11.035.
73. Loprinzi PD, Frith E, Cardiometabolic healthy obesity paradigm and all-cause mortality risk. Eur J Intern Med 2017 43 42 45. doi: 10.1016/j.ejim.2017.05.013.
74. Zheng R, Zhou D, Zhu Y, The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis. J Epidemiol Community Health 2016 70 1024 1031. doi: 10.1136/jech-2015-206948.
75. Sharma AM, Kushner RF, A proposed clinical staging system for obesity. Int J Obes (Lond) 2009 33 289 295. doi: 10.1038/ijo.2009.2.
76. Padwal RS, Pajewski NM, Allison DB, Sharma AM, Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ 2011 183 E1059 E1066. doi: 10.1503/cmaj.110387.
77. Bastien M, Poirier P, Lemieux I, Després JP, Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014 56 369 381. doi: 10.1016/j.pcad.2013.10.016.
78. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE, Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002 346 793 801. doi: 10.1056/NEJMoa011858.
79. Huot M, Arsenault BJ, Gaudreault V, Poirier P, Pérusse L, Tremblay A, Bouchard C, Després JP, Rhéaume C, Insulin resistance, low cardiorespiratory fitness, and increased exercise blood pressure: contribution of abdominal obesity. Hypertension 2011 58 1036 1042. doi: 10.1161/HYPERTENSIONAHA.111.180349.
80. Rhéaume C, Arsenault BJ, Bélanger S, Pérusse L, Tremblay A, Bouchard C, Poirier P, Després JP, Low cardiorespiratory fitness levels and elevated blood pressure: what is the contribution of visceral adiposity? Hypertension 2009 54 91 97. doi: 10.1161/HYPERTENSIONAHA.109.131656.
81. Rhéaume C, Arsenault BJ, Dumas MP, Pérusse L, Tremblay A, Bouchard C, Poirier P, Després JP, Contributions of cardiorespiratory fitness and visceral adiposity to six-year changes in cardiometabolic risk markers in apparently healthy men and women. J Clin Endocrinol Metab 2011 96 1462 1468. doi: 10.1210/jc.2010-2432.
82. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN, Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 2005 28 391 397
83. Ortega FB, Cadenas-Sánchez C, Sui X, Blair SN, Lavie CJ, Role of fitness in the metabolically healthy but obese phenotype: a review and update. Prog Cardiovasc Dis 2015 58 76 86. doi: 10.1016/j.pcad.2015.05.001.
84. Bell JA, Hamer M, Sabia S, Singh-Manoux A, Batty GD, Kivimaki M, The natural course of healthy obesity over 20 years. J Am Coll Cardiol 2015 65 101 102. doi: 10.1016/j.jacc.2014.09.077.
85. Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB, Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis. Eur J Prev Cardiol 2016 23 956 966. doi: 10.1177/2047487315623884.
86. Cornier MA, Després JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, Lopez-Jimenez F, Rao G, St-Onge MP, Towfighi A, Poirier P, American Heart Association Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council on the Kidney in Cardiovascular Disease; and Stroke Council Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011 124 1996 2019. doi: 10.1161/CIR.0b013e318233bc6a.
87. Cerhan JR, Moore SC, Jacobs EJ, Kitahara CM, Rosenberg PS, Adami HO, Ebbert JO, English DR, Gapstur SM, Giles GG, Horn-Ross PL, Park Y, Patel AV, Robien K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Hartge P, Bernstein L, Berrington de Gonzalez A, A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc 2014 89 335 345. doi: 10.1016/j.mayocp.2013.11.011.
88. Lassale C TI, Moons KGM, Sweeting M, Boer J, Johnson L, Huerta JM, Agnoli C, Freisling H, Weiderpass E, Wennberg P, van der A DL, Arriola L, Benetou V, Boeing H, Bonnet F, Colorado-Yohar SM, Engström G, Eriksen AK, Ferrari P, Grioni S, Johansson M, Kaaks R, Katsoulis M, Katzke V, Key TJ, Matullo G, Melander O, Molina-Portillo E, Moreno-Iribas C, Norberg M, Overvad K, Panico S, Quirós JR, Saieva C, Skeie G, Steffen A, Stepien M, Tjønneland A, Trichopoulou A, Tumino R, van der Schouw YT, Verschuren WMM, Langenberg C, Di Angelantonio E, Riboli E, Wareham NJ, Danesh J, Butterworth AS, Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis. Eur Heart J 2018 39 397 406. doi: 10.1093/eurheartj/ehx448.
89. Nazare JA, Smith J, Borel AL, Aschner P, Barter P, Van Gaal L, Tan CE, Wittchen HU, Matsuzawa Y, Kadowaki T, Ross R, Brulle-Wohlhueter C, Alméras N, Haffner SM, Balkau B, Després JP, INSPIRE ME IAA Investigators Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). Am J Cardiol 2015 115 307 315. doi: 10.1016/j.amjcard.2014.10.039.
90. Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A, Alméras N, Bergeron J, Gaudet D, Tremblay G, Prud'homme D, Nadeau A, Després JP, Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 2000 102 179 184
91. Lemieux I, Poirier P, Bergeron J, Alméras N, Lamarche B, Cantin B, Dagenais GR, Després JP, Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? Can J Cardiol 2007 23 suppl B 23B 31B
92. Neeland IJ, Grundy SM, Li X, Adams-Huet B, Vega GL, Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study. Nutr Diabetes 2016 6 e221. doi: 10.1038/nutd.2016.28.
93. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, Hu FB, Hubbard VS, Jakicic JM, Kushner RF, Loria CM, Millen BE, Nonas CA, Pi-Sunyer FX, Stevens J, Stevens VJ, Wadden TA, Wolfe BM, Yanovski SZ, Jordan HS, Kendall KA, Lux LJ, Mentor-Marcel R, Morgan LC, Trisolini MG, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology/American Heart Association Task Force on Practice Guidelines; The Obesity Society 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014 129 suppl 2 S102 S138. doi: 10.1161/01.cir.0000437739.71477.ee.
94. Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Després JP, Ndumele CE, Vijayaraghavan K, Handelsman Y, Puckrein GA, Araneta MR, Blum QK, Collins KK, Cook S, Dhurandhar NV, Dixon DL, Egan BM, Ferdinand DP, Herman LM, Hessen SE, Jacobson TA, Pate RR, Ratner RE, Brinton EA, Forker AD, Ritzenthaler LL, Grundy SM, The CardioMetabolic Health Alliance: working toward a new care model for the metabolic syndrome. J Am Coll Cardiol 2015 66 1050 1067. doi: 10.1016/j.jacc.2015.06.1328.
95. Borel AL, Nazare JA, Smith J, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP, Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program. Obesity (Silver Spring) 2012 20 1223 1233. doi: 10.1038/oby.2011.396.
96. Borel AL, Nazare JA, Baillot A, Alméras N, Tremblay A, Bergeron J, Poirier P, Després JP, Cardiometabolic risk improvement in response to a 3-yr lifestyle modification program in men: contribution of improved cardiorespiratory fitness vs. weight loss. Am J Physiol Endocrinol Metab 2017 312 E273 E281. doi: 10.1152/ajpendo.00278.2016.
97. Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorlí JV, Martínez JA, Martínez-González MA, PREDIMED Study Investigators Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013 368 1279 1290. doi: 10.1056/NEJMoa1200303.
98. Broekhuizen LN, Boekholdt SM, Arsenault BJ, Despres JP, Stroes ES, Kastelein JJ, Khaw KT, Wareham NJ, Physical activity, metabolic syndrome, and coronary risk: the EPIC-Norfolk prospective population study. Eur J Cardiovasc Prev Rehabil 2011 18 209 217. doi: 10.1177/1741826710389397.
99. Chaston TB, Dixon JB, Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond) 2008 32 619 628. doi: 10.1038/sj.ijo.0803761.
100. Verheggen RJ, Maessen MF, Green DJ, Hermus AR, Hopman MT, Thijssen DH, A systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue. Obes Rev 2016 17 664 690. doi: 10.1111/obr.12406.
101. Vissers D, Hens W, Taeymans J, Baeyens JP, Poortmans J, Van Gaal L, The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One 2013 8 e56415. doi: 10.1371/journal.pone.0056415.
102. Després JP, Obesity and cardiovascular disease: weight loss is not the only target. Can J Cardiol 2015 31 216 222. doi: 10.1016/j.cjca.2014.12.009.
103. Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U, Ryan DH, Still CD, Endocrine Society Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2015 100 342 362. doi: 10.1210/jc.2014-3415.
104. Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, Niskanen L, Rasmussen MF, Rissanen A, Rössner S, Savolainen MJ, Van Gaal L, NN8022-1807 Investigators Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide. Int J Obes (Lond) 2012 36 843 854. doi: 10.1038/ijo.2011.158.
105. Piché MÈ Auclair A, Harvey J, Marceau S, Poirier P, How to choose and use bariatric surgery in 2015. Can J Cardiol 2015 31 153 166. doi: 10.1016/j.cjca.2014.12.014.
106. Dadson P, Landini L, Helmiö M, Hannukainen JC, Immonen H, Honka MJ, Bucci M, Savisto N, Soinio M, Salminen P, Parkkola R, Pihlajamäki J, Iozzo P, Ferrannini E, Nuutila P, Effect of bariatric surgery on adipose tissue glucose metabolism in different depots in patients with or without type 2 diabetes. Diabetes Care 2016 39 292 299. doi: 10.2337/dc15-1447.
107. Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH, Long-term follow-up after bariatric surgery: a systematic review. JAMA 2014 312 934 942. doi: 10.1001/jama.2014.10706.
108. Rodriguez Flores M, Aguilar Salinas C, Piché ME, Auclair A, Poirier P, Effect of bariatric surgery on heart failure. Expert Rev Cardiovasc Ther 2017 15 567 579. doi: 10.1080/14779072.2017.1352471.
109. Gaborit B, Jacquier A, Kober F, Abdesselam I, Cuisset T, Boullu-Ciocca S, Emungania O, Alessi MC, Clément K, Bernard M, Dutour A, Effects of bariatric surgery on cardiac ectopic fat: lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol 2012 60 1381 1389. doi: 10.1016/j.jacc.2012.06.016.